Related references
Note: Only part of the references are listed.Current concepts on the role of inflammation in COPD and lung cancer
Hongwei Yao et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
Serum autoantibodies as biomarkers for early cancer detection
Hwee Tong Tan et al.
FEBS JOURNAL (2009)
Establishment of a Multi-Analyte Serum Biomarker Panel to Identify Lymph Node Metastases in Non-small Cell Lung Cancer
Jeffrey A. Borgia et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Lung Cancer Diagnostic and Treatment Intervals in the United States A Health Care Disparity?
Jeffrey T. Yorio et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Autoantibodies in lung cancer:: possibilities for early detection and subsequent cure
C. J. Chapman et al.
THORAX (2008)
Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection
Thomas A. D'Amico et al.
ANNALS OF THORACIC SURGERY (2006)
A combination of molecular markers accurately detects lymph node metastasis in non-small cell lung cancer patients
LQ Xi et al.
CLINICAL CANCER RESEARCH (2006)
Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis - M-CSF - An independent prognostic factor
Janina Kaminska et al.
ONCOLOGY (2006)
Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancer
L Boldrini et al.
BRITISH JOURNAL OF CANCER (2005)
Lung cancer screening
JL Mulshine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Novel strategies for the early detection and prevention of lung cancer
NR Wardwell et al.
SEMINARS IN ONCOLOGY (2005)
Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: A review
S Singhal et al.
CLINICAL CANCER RESEARCH (2005)
Screening for non-small cell lung cancer
RW Ashton et al.
SEMINARS IN ONCOLOGY (2005)
Clinical application of biological markers for treatments of resectable non-small-cell lung cancers
C Huang et al.
BRITISH JOURNAL OF CANCER (2005)
Early diagnosis of lung cancer by detection of tumor liberated protein
G Tarro et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Molecular prognostic factors in resectable non-small cell lung cancer
P Vielh et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2005)
The prognostic significance of vascular endothelial growth factor levees in sera of non-small cell lung cancer patients
A Kaya et al.
RESPIRATORY MEDICINE (2004)
Prognostic factors in resected stage I non-small-cell lung cancer: A multivariate analysis of six molecular markers
C Lu et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer
A Onn et al.
CLINICAL CANCER RESEARCH (2004)
Tumor markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in patients with non-small cell lung cancer as an aid in histological diagnosis and prognosis - Comparison with the main clinical and pathological prognostic factors
R Molina et al.
TUMOR BIOLOGY (2003)
Prognostic significance of cytokine modulation in non-small cell lung cancer
A Neuner et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Prognostic value of serum tumor markers in patients with lung cancer
KD Hatzakis et al.
RESPIRATION (2002)
Share Paper
